期刊
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
卷 40, 期 4, 页码 263-272出版社
ELSEVIER
DOI: 10.1016/j.ejps.2010.03.022
关键词
Cytochrome P450; Drug metabolism; Nuclear receptor; CAR; PXR; CYP3A4
资金
- Finnish Funding Agency for Technology and Innovation (TEKES)
- Academy of Finland
- Graduate School in Pharmaceutical Research
Most hepatoma cell lines lack proper expression and induction of cytochrome P450 (CYP) enzymes and this deficiency hampers their use as in vitro models for drug and xenobiotic metabolism. According to previous studies, the poor expression of CYP enzymes may be due to decreases in CYP gene transcription. Two nuclear receptors (NRs), the pregnane X receptor (PXR) and the constitutive androstane receptor (CAR), are known to regulate many genes involved in xenobiotic metabolism and disposition. Here, we studied the expression of different CYR, NR and NR co-regulator genes in hepatoma cell lines. Next, we created chimeric NR constructs by cloning the strong activation domain from the p65 subunit of transcription factor NF-kappa B and appending it to either N- or C-termini of the human CAR or PXR. We established that these chimeric NRs displayed enhanced trans-activation potential as compared to the unmodified NRs, and showed that transient transfection of a single chimeric NR increased the expression of several CYPs simultaneously. Finally, stable cell lines expressing a chimeric NR had elevated levels of CYP3A4. CYP2B6 and CYP2C9 mRNAs and CYP3A4-mediated metabolism when compared to the wild-type hepatoma cells. These findings establish a proof of principle how improved metabolic cell models could be designed. (C) 2010 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据